Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator. Its exact mechanism of action is not fully understood, but it is believed to relax vascular smooth muscle.
## Primary Indications
* Treatment of peripheral vascular diseases such as arteriosclerosis obliterans and Raynaud's disease.
* Adjunctive therapy in conditions associated with insufficient cerebral blood flow.
## Adult Dosing
* **Oral:** The usual dose is 10 mg to 20 mg, 3 to 4 times daily.
* Maximum dose: Not explicitly defined, but higher doses may increase the risk of adverse effects.
## Pediatric Dosing
* There is no established pediatric dosing for isoxsuprine hydrochloride. Safety and efficacy have not been determined in this population.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are routinely recommended. Use with caution, as drug accumulation may occur.
* **Hepatic Impairment:** No specific dose adjustments are routinely recommended. Use with caution, as drug accumulation may occur.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use in patients with congenital heart disease or arrhythmias.
* Use in patients who have recently experienced a stroke or myocardial infarction.
## Adverse Effects
* **Cardiovascular:** Hypotension, dizziness, lightheadedness, tachycardia, palpitations.
* **Gastrointestinal:** Nausea, vomiting, abdominal distress, heartburn.
* **Neurological:** Weakness, nervousness, flushing.
* **Other:** Rash, blurred vision.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the effects of antihypertensive medications, leading to additive hypotension.
* **Sympathomimetics:** Concurrent use may lead to additive cardiovascular effects (e.g., tachycardia).
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease.
* Signs of adverse effects, particularly cardiovascular and gastrointestinal symptoms.
## Clinical Pearls
* Isoxsuprine is generally not considered a first-line agent for peripheral vascular disease.
* Its efficacy in improving circulation and relieving symptoms is variable and often debated.
* Patients should be advised to rise slowly from a sitting or lying position to minimize orthostatic hypotension.
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for complete details before making any clinical decisions. Dosing and indications may vary based on specific patient factors and local protocols.
